New research led by the UNC Gillings School of Global Public Health shows that bivalent COVID-19 boosters are still providing effective protection from hospitalization and death, even against the most recent omicron subvariants.
Apr 13, 2023
0
0
Between natural infection and a global vaccination campaign, most people now have some immunity against the virus that causes COVID-19. This widespread immunity hasn't stopped people from getting infected, but it has dampened ...
Apr 3, 2023
0
62
The World Health Organization said Tuesday it is no longer recommending additional COVID-19 vaccine booster doses for regular, medium-risk adults as the benefit was marginal.
Mar 28, 2023
0
2
China has approved its first locally developed messenger RNA (mRNA) vaccine against COVID-19, its manufacturer said Wednesday, months after the relaxation of strict COVID-zero regulations sparked a surge in cases.
Mar 22, 2023
0
2
According to an accepted manuscript published in ARRS' American Journal of Roentgenology (AJR), axillary lymphadenopathy after a COVID-19 vaccine booster dose has a mean time to resolution of 102 days, shorter than the time ...
Mar 9, 2023
0
35
The original vaccinations for COVID-19 induce potent antibodies that protect against SARS-CoV-2.
Feb 15, 2023
1
137
COVID-19 booster shots appear to benefit folks 50 and older but less so for younger people, a new study suggests.
Feb 13, 2023
0
9
For the first time, COVID-19 vaccines have been added to the list of routine immunizations recommended for adults—a further sign the virus is here to stay.
Feb 10, 2023
0
3
Australians aged 18 and over will be eligible for a COVID booster from February 20 if they have not had a vaccine dose or infection in the past six months.
Feb 8, 2023
0
1
Jeffrey Townsend, Ph.D., is Yale's Elihu Professor of Biostatistics and Professor of Ecology and Evolutionary Biology. Dr. Townsend's research focuses on disease evolution and transmission including curtailment of pathogen ...
Jan 30, 2023
0
4
